FC Copenhagen handed challenging Europa League group

Lions up against Zenit St Petersburg, Bordeaux and Slavia Prague

Last night FC Copenhagen defeated Seria A side Atalanta in a nail-biting affair to reach the Europa League group stage.

Today it was revealed that FCK will be forced to conjure up wins against stern opposition once again in the near future if they hope to progress to the knockout stages after being drawn in Group C along with Zenit St Petersburg, Bordeaux and Slavia Prague.

READ MORE: FC Copenhagen overcome Atalanta in Europa League drama

Tickets next week
The fixtures have yet to be decided, but the first round match will take place on September 20 and ticket sales will begin sometime at the start of next week. Keep an eye out on Fck.dk for further news.

The other rounds will be played on October 4 and 25, November 8 and 29 and December 13.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.